Basic Fund Data
Fund Provider:	XShares Group
Asset Class:	Closed Funds
Fund Category:	Closed Funds
Ticker:	HHV
Expense Ratio:	0.60%
Fund Category Expense Ratio Average:	0.52%
Options:	No
Fund Inception Date:	01-23-2007
Fund Structure:	Open-Ended
Fund Weighting Restrictions:	Non-diversified Fund Rules
Fund Tracking Method:	Full Replication
Dividend Payment Frequency:
Basic Index Data
Index Name:	HealthShares Drug Discovery Tools Index
Index Provider:	HealthShares
No of Index Holdings:	Under 100
Explanation of Index Strategy
Security Selection Category:	Screened
Security Selection Method:	Thematic
Security Selection Frequency:	Quarterly
Index Weighting Category:	Fixed Weight
Index Weighting Method:	Equal then Float
Index Weighting Frequency:	Each Stock as Needed

No Data Found

No Data Found

No Data Found

Index Snapshot:

THIS ETF HAS BEEN LIQUIDATED AS OF DECEMBER 2008. The HealthShares Drug Discovery Tools ETF (Ticker: HHV) seeks to replicate as closely as possible, before expenses, the total return performance of the HealthShares Drug Discovery Tools Index. The index is comprised of companies that provide technology products and/or services that enable and support the discovery, clinical development and manufacturing activities of pharmaceutical and biotechnology companies, including but not limited to genomics, proteomics, and high throughput screening. Companies must have a minimum market capitalization greater than $100 million and less than $15 billion for at least two of the three proceeding quarters. Maximum weight for a security in the index is 15%. Stocks are equally weighted when the fund is formed and then float with the market thereafter. When the weight of an individual stock reaches 15% of the index value it is adjusted down to 10%, and when a stocks falls to 2.5% it is adjusted up to 5%. S&P is the administrator of HealthShares indexes.